Awridian has a proven track record with a range of groups across Drug Discovery, these include start-ups, small bio-techs, pharmaceutical companies, and academics.
With expertise in lead generation and subsequent optimisation that is illustrated by patents, publications and presentations which include topics such as new modalities, screening compounds, fragments and building block design and acquisition.
Awridian can move your project forward by identifying a supplier of the required service for example chemistry (arrays, test compound, fragments, or intermediates) or biological assays (HTS, DEL, ASMS, in vitro, in vivo and DMPK). Furthermore, Awridian recognises that acquiring the appropriate compounds either for hit identification projects, or for larger projects such as refreshing your screening collection is critical. In addition, Awridian can advise on the tractability of Medicinal Chemistry Projects and how to enhance your chance of success.
Awridian is a strong advocate of open innovation in drug discovery, and the evolving landscape of charity sector’s engagement with drug discovery.
Please email to discuss your requirements.